RareCyte, Inc. retweeted
"The explosive development of advanced technologies has let us explore the intricate cellular and molecular interactions in tissues with incredible precision and resolution, and at scale." – Dr. Zhihong Chen, OCCAM Immune
Learn more: eu1.hubs.ly/H0gF-Z70
@RareCyte
RareCyte, Inc. retweeted
LSW members @RareCyte and @AlpenglowBio were ranked among the top 10 spatial biology companies of 2024.
Read more: lifesciencewajobs.com/2024/1…
#FindYourBestLifeinWA #SpatialBiology
RareCyte, Inc. retweeted
Highly educational talks from Mr. Evan Mills, VP of @OlinkProteomics, and Dr. Ted George, Senior VP of @RareCyte, at #PrIISM2024! They showcased the innovative Olink Explore HT & Orion Multiplex IF, both successfully implemented at HIMC to advance scientific research.
RareCyte, Inc. retweeted
🔬Orion is a powerful research tool that is useful for training ML algorithms for computational pathology - especially for identifying cell types that are difficult to distinguish from H&E images alone.
The open-access publication is available here: nature.com/articles/s43018-0…
RareCyte, Inc. retweeted
Replying to @Pankind_Aus
We use a simple blood test "liquid biopsy" to detect very rare circulating tumour cells - offering the possibility of earlier detection and improved monitoring
@RareCyte @eurordis @RareVoices
frontiersin.org/journals/onc…
RareCyte, Inc. retweeted
#ImageOfTheDay🖼️
I’m in awe of the level of detail in the imagery outlining the immune micro environment surrounding a #cancer as shown here as an example.
🟢PanCK
🔴Ki67
⚪️CD3
There are only so many colors🌈that one’s🧠 can process tangibly.
Orion 13-plex IF Panel. @RareCyte – at Queens, NY
RareCyte, Inc. retweeted
So grateful for this amazing team! 🤩 Lola the CycIF queen music video featuring all cells in the #tumormicroenvironment @RareCyte #oncosys @HiLIFE_helsinki @HelsinkiUniMed
RareCyte, Inc. retweeted
And immediately things started rolling!💪🏼🎉 New scanner has been given the name Dolores alias Lola and she is perfect! Thank you @RareCyte for bringing her home safely! looking forward to all the #spatialomics data we can now generate! @SystemTumor
RareCyte, Inc. retweeted
Thrilled to share that LJI's Dr. Estefania Quesada Masachs has won the @DiabetesnPOD Young Investigator of the Year Award for type 1 diabetes discoveries: bit.ly/43GU0kY
#T1D #AutoimmuneDisease #diabetes #SanDiego
RareCyte, Inc. retweeted
RareCyte Moving Into Higher-Plex Spatial Proteomics. The firm believes its Orion system's combination of multiplexing, data quality, and throughput will help it carve out a space in an increasingly crowded market. ow.ly/uwYk104vYnC
RareCyte, Inc. retweeted
In our latest Q&A, Selena Larkin, CCO of @RareCyte, discusses Rarecyte’s product roadmap and notable R&D developments in Spatial Biology and Liquid Biopsy.
Read about it here: decibio.com/insights/the-pla…
#technology #innovation #interview #marketdynamics
RareCyte, Inc. retweeted
In this article, Dr. David Rimm sheds light on the power of multiplex imaging in enhancing breast cancer #diagnostics, enabling a match between the patient's cancer phenotype and the most suitable therapies: bit.ly/3lInbSR
@RareCyte #Cancer #Cancerresearch
RareCyte, Inc. retweeted
What if we could solve the most urgent health challenges of our time faster? We think we can.
Leap's HBNet is the largest, most rapidly 'activatable' research network in the world — now 100+ partners on 6 continents, representing over 1M researchers. #morebreakthroughsfaster
RareCyte, Inc. retweeted
Join us at the Biomarker and CDx Virtual Conference and listen to our CMO, Eric Kaldjian, MD present at 9:30 a.m. PST on the Orion™ spatial biology platform!
lnkd.in/gKA37B8
#biomarker #pathology #ctcs #multiplexedimaging #spatialanalysis #spatialbiology #multiplexing
RareCyte, Inc. retweeted
If you're attending the @OGConferences Virtual Symposium: #DigitalPathology, don't miss this presentation tomorrow, Oct 15th! Registration details in the link below.
@Indica_Labs’ Pharma Services: Facilitating Tissue Based #ImmunoOncology Research
indicalab.com/news/indica-la…
RareCyte, Inc. retweeted
Don’t forget to register for the virtual #PathVisions20 meeting at the end of the month! Join us at our workshop and live Q&A with @HussDoc, @GiorgioSeano and Visiopharm’s own @DanWinkowski
Learn more and sign up today: hubs.ly/H0xv3760
RareCyte, Inc. retweeted
Log in to SITC’s #VIRTUAL #Pittsburgh Advances in Cancer Immunotherapy™ live program on Oct. 24 to stay current on FDA-approved #immunotherapy Treatments and obtain free CME-, CNE-, CPE- and MOC-credits. Participate from your own office or home. sitcancer.org/education/aci/… #LearnACI
RareCyte, Inc. retweeted
Join us for our workshop and live Q&A at #PathVisions20 on Monday, October 26th! Learn more about our presentation and meet our speakers here: hubs.ly/H0x2Q_80
#digitalpathology #breastcancer # glioblastoma
RareCyte, Inc. retweeted

Joseph Vacca@JosephVacca22 Aug 2020
🇺🇸
United StatesConnected via United States App StoreAccount-level information, not a live location or per-post device.
I am attending Next Generation #Diagnostics Virtual Interactive Global Summit next week. Would you like to attend?
#genomics #sequencing #ngs #covid19testing #infectiousdiseases lnkd.in/dtGmgAz
RareCyte, Inc. retweeted
The format has changed, but the mission remains the same. Join us August 25-27 as the #diagnostics community gathers for the 12th year pursuing their common goal: Advancing Diagnostics Together.
View our esteemed speaker faculty at nextgenerationdx.com/
Next Generation Dx Summit
Learn more about the leading event serving the international diagnostics community - CHI's 12th Annual Next Generation Dx Virtual Summit - August 25-27, 2020.



























